Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL20513680 | 0.98 | ATM (0.51) | ATMCYP2C9CYP2C19ALDH1A1THRB | |
| Methylene Chloride SCHEMBL29038775 | 0.96 | ATM (0.50) | ATMCYP2C9CYP2C19ALDH1A1THRB | |
| SCHEMBL4393180 | 0.87 | LTA4H (0.67) | NPC1RAB9AMMP8LAP3 | |
| SCHEMBL10776860 | 0.85 | CYP1A2 (0.49) | ATMCYP2C9CYP2C19ALDH1A1THRB | |
| SCHEMBL3248350 | 0.84 | L3MBTL1 (0.49) | ATMALDH1A1KMT2AMEN1NPC1 | |
| SCHEMBL4816689 | 0.84 | ESR1 (0.63) | KMT2ANPC1RAB9AMIF | |
| SCHEMBL163965 | 0.84 | NOS2 (0.47) | ALDH1A1KMT2AMEN1POLBL3MBTL1 | |
| SCHEMBL1597773 | 0.84 | MMP8 (0.58) | ALDH1A1HSD17B10KMT2AMEN1POLB | |
| SCHEMBL31408748 | 0.84 | TSHR (0.56) | CYP2C9CYP2C19ALDH1A1THRBHSD17B10 | |
| SCHEMBL977403 | 0.84 | ESR1 (0.46) | ATMCYP2C9CYP2C19ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284530-B | Preparation method and application of butyl rubber | 山东京博中聚新材料有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-116284530-A | Preparation method and application of butyl rubber | 山东京博中聚新材料有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116284530-B | Preparation method and application of butyl rubber | 山东京博中聚新材料有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-116284530-A | Preparation method and application of butyl rubber | 山东京博中聚新材料有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-108601837-A | extended release fragrance composition | 雅芳产品公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-1820030-B | Process for the production of living radical polymers and polymers | OTSUKA CHEMICAL CO LTD | 2010-10-06 | — | — | CN | disclosed |
| CN-101801194-A | Has 5-HT 63 ' the compound that replaces of receptor affinity | MEMORY PHARM CORP | 2010-08-11 | — | — | CN | disclosed |
| EP-2184990-A2 | 3' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | Memory Pharmaceuticals Corporation (US) | 2010-05-19 | — | — | EP | disclosed |
| US-20100056491-A1 | 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100056531-A1 | ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100056531-A1 | ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-4670579-A | Telomerization of olefins | ETHYL CORPORATION (US) | 1987-06-02 | — | — | US | disclosed |
| EP-0115403-B1 | ABSORBABLE POLYMERS OF SUBSTITUTED BENZOIC ACID | ETHICON, INC. (US) | 1987-05-13 | — | — | EP | disclosed |
| US-4604243-A | ONE STEP-ARYLAMINE IN PRESENCE OF ALKYL NITRITE, HALOGEN COMPOUND, AND COPPER CATALYST | ETHYL CORPORATION (US) | 1986-08-05 | — | — | US | disclosed |
| US-4594450-A | Hydrolysis of the corresponding halogen containing ethylbenzene derivative | TOYO SODA MANUFACTURING CO., LTD. (JP) | 1986-06-10 | — | — | US | disclosed |
| US-4534909-A | Process for producing a halogen-containing ethylbenzene derivative | TOYO SODA MANUFACTURING CO., LTD. (JP) | 1985-08-13 | — | — | US | disclosed |
| US-4532928-A | RADIATION STERILIZABLE | ETHICON, INC. (US) | 1985-08-06 | — | — | US | disclosed |
| EP-0140229-A1 | Process for producing a halogen-containing ethylbenzene derivative | Tosoh Corporation (JP) | 1985-05-08 | — | — | EP | disclosed |
| US-4510295-A | POLYESTER COPOLYMERS; FIBERS, SUTURES, SURGICAL PRODUCTS | ETHICON, INC. (US) | 1985-04-09 | — | — | US | disclosed |
| EP-0115403-A1 | Absorbable polymers of substituted benzoic acid | ETHICON, INC. (US) | 1984-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056531-A1 | ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | HTR6, HTR3B, HTR1B | ATM 2729/4885CYP2C9 559/4885CYP2C19 411/4885 |
| US-20100056491-A1 | 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | HTR6, HTR4, HTR3B | ATM 2019/4885CYP2C9 699/4885CYP2C19 426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.